UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients

British journal of clinical pharmacology, 2017-08, Vol.83 (8), p.1758-1772

2017

Volltextzugriff (PDF)

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

Clinical cancer research, 2014-02, Vol.20 (3), p.754-763

2014

Volltextzugriff (PDF)

The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep

International journal of molecular sciences, 2020-04, Vol.21 (9), p.3042

2020

Volltextzugriff (PDF)

A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2013-05, Vol.12 (3), p.129-140

2013

Volltextzugriff (PDF)

A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients

Clinical cancer research, 2008-07, Vol.14 (13), p.4213-4218

2008

Volltextzugriff (PDF)

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models

Computer methods and programs in biomedicine, 1999-04, Vol.59 (1), p.19-29

1999

Volltextzugriff (PDF)

Lack of Association of Single-Nucleotide Polymorphisms in Pregnane X Receptor, Hepatic Nuclear Factor 4α, and Constitutive Androstane Receptor with Docetaxel Pharmacokinetics

Clinical cancer research, 2007-12, Vol.13 (23), p.7126-7132

2007

Volltextzugriff (PDF)

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

British journal of clinical pharmacology, 2012-08, Vol.74 (2), p.267-283

2012

Volltextzugriff (PDF)

Population Pharmacokinetics of Humanized Monoclonal Antibody HuCC49ΔCH2 and Murine Antibody CC49 in Colorectal Cancer Patients

Journal of clinical pharmacology, 2007-02, Vol.47 (2), p.227-237

2007

Volltextzugriff (PDF)

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Thorax, 2019-08, Vol.74 (8), p.740-748

2019

Volltextzugriff (PDF)

Safe and effective variability-a criterion for dose individualization

Therapeutic drug monitoring, 2012-10, Vol.34 (5), p.565-568

2012

Volltextzugriff (PDF)

SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4122-4127

2011

Volltextzugriff (PDF)

Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics

Journal of pharmacokinetics and pharmacodynamics, 2014-02, Vol.41 (1), p.15-33

2014

Volltextzugriff (PDF)

Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

British journal of clinical pharmacology, 2012-08, Vol.74 (2), p.284-295

2012

Volltextzugriff (PDF)

Population clinical pharmacology of children : modelling covariate effects

European journal of pediatrics, 2006-12, Vol.165 (12), p.819-829

2006

Volltextzugriff (PDF)

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

British journal of clinical pharmacology, 2007-01, Vol.63 (1), p.75-84

2007

Volltextzugriff (PDF)

Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

Clinical pharmacokinetics, 2015-12, Vol.54 (12), p.1287-1288

2015

Volltextzugriff (PDF)

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis

European journal of clinical pharmacology, 2012-05, Vol.68 (5), p.689-695

2012

Volltextzugriff (PDF)

Dyskinesia and the antiparkinsonian response always temporally coincide: a retrospective study

Neurology, 2010-04, Vol.74 (15), p.1191-1197

2010

Volltextzugriff (PDF)

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

European journal of clinical pharmacology, 2013-07, Vol.69 (7), p.1411-1421

2013

Volltextzugriff (PDF)

Population clinical pharmacology of children : general principles

European journal of pediatrics, 2006-11, Vol.165 (11), p.741-746

2006

Volltextzugriff (PDF)

Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimens

British journal of clinical pharmacology, 2010-11, Vol.70 (5), p.682-693

2010

Volltextzugriff (PDF)

Acetaminophen developmental pharmacokinetics in premature neonates and infants: A pooled Population analysis

Anesthesiology (Philadelphia), 2002-06, Vol.96 (6), p.1336-1345

2002

Volltextzugriff (PDF)

Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models"

Therapeutic drug monitoring, 2013-12, Vol.35 (6), p.873-874

2013

Volltextzugriff (PDF)

A size standard for pharmacokinetics

Clinical pharmacokinetics, 1996-05, Vol.30 (5), p.329-332

HOLFORD, N. H. G

1996

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(93)
Buchkapitel
(9)

Sprache

Englisch
(102)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep

A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models

A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models

Lack of Association of Single-Nucleotide Polymorphisms in Pregnane X Receptor, Hepatic Nuclear Factor 4α, and Constitutive Androstane Receptor with Docetaxel Pharmacokinetics

Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

Population Pharmacokinetics of Humanized Monoclonal Antibody HuCC49ΔCH2 and Murine Antibody CC49 in Colorectal Cancer Patients

Pseudomonas aeruginosa eradication therapy and risk of acquiring Aspergillus in young children with cystic fibrosis

Safe and effective variability-a criterion for dose individualization

SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications

Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics

Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

Population clinical pharmacology of children : modelling covariate effects

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance

Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis

Dyskinesia and the antiparkinsonian response always temporally coincide: a retrospective study

The population pharmacokinetics of allopurinol and oxypurinol in patients with gout

Population clinical pharmacology of children : general principles

Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimens

Acetaminophen developmental pharmacokinetics in premature neonates and infants: A pooled Population analysis

Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models"

A size standard for pharmacokinetics

Suchergebnisse filtern